TRIAL DETAIL
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen.
Drug: |
||||
|---|---|---|---|---|
Trial Name: |
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen. |
|||
NCT#: |
||||
Conditions: |
Gastrointestinal Stromal Tumor |
|||
Status: |
Completed |
|||
Phase: |
1 |
Start Date 05/01/2007 |
Age of Trial (yrs) 17.9 |
|
Treatment Phase: |
Gleevec-resistant |
|||
Drug Category: |
Virotherapy |
|||
Strategy: |
Stimulate the immune system |
|||
Trial Type: |
Specifically GIST plus other cancers |
|||
Other Protocol IDs: |
LUD2005-003, EudraCT:2006-002015-27 |
|||
Sponsor: |
Ludwig Institute for Cancer Research |
|||
Patient Contact: |
See site contact info below |
|||
Contact email: |
||||
Contact Phone: |
||||
Randomized: |
||||
IV or Oral: |
Intravenous |
|||
Trial Notes: |
||||
Trial Links |
Trial Results |
Drug Information |
Trial Sites
Name |
Address |
City |
State |
Zip |
Country |
Frankfurt |
Germany |